Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Abstract Background Polypharmacy is associated with poorer health outcomes in older adults. Other than the associated multimorbidity, factors contributing to this association could include medication adverse effects and interactions, difficulties in managing complicated medication regimes, and reduc...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Dee Mangin, Larkin Lamarche, Gina Agarwal, Abbas Ali, Alan Cassels, Kiska Colwill, Lisa Dolovich, Naomi Dore Brown, Barbara Farrell, Karla Freeman, Kristina Frizzle, Scott R. Garrison, James Gillett, Anne Holbrook, Jane Jurcic-Vrataric, James McCormack, Jenna Parascandalo, Julie Richardson, Cathy Risdon, Diana Sherifali, Henry Siu, Sayem Borhan, Jeffery A. Templeton, Lehana Thabane, Johanna Trimble
Format: Artykuł
Język:English
Wydane: BMC 2023-05-01
Seria:Pilot and Feasibility Studies
Hasła przedmiotowe:
Polypharmacy
Deprescribing
Multi-morbidity
Patient safety
Primary care
Dostęp online:https://doi.org/10.1186/s40814-023-01315-0

Internet

https://doi.org/10.1186/s40814-023-01315-0

Podobne zapisy